Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer pharmacogenomics: current and future applications.

James W Watters1, Howard L McLeod

  • 1Department of Medicine, Washington University School of Medicine, 660 S Euclid Ave-Campus Box 8069, St Louis, MO 63110, USA.

Biochimica Et Biophysica Acta
|March 6, 2003
PubMed
Summary

Pharmacogenomics tailors cancer therapy by analyzing genetic differences that affect drug response. This approach optimizes chemotherapy efficacy and minimizes toxicity for individual patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating Somatic and Germline Pharmacogenomics for Therapeutic Decisions in Precision Oncology.

JCO precision oncology·2026
Same author

Propranolol metabolite and enantiomers affect colorectal cancer development by inhibiting MAPK pathway and downregulating PD-1 expression.

International immunopharmacology·2025
Same author

A two-stage genome-wide association study to identify novel genetic loci associated with irAEs in lung cancer patients receiving PD-1/PD-L1 inhibitors.

Cancer letters·2025
Same author

Advancing the science of genomic learning healthcare systems.

Learning health systems·2025
Same author

Causal effects of immune cells on the efficacy and adverse drug reactions of platinum drugs.

Acta biochimica et biophysica Sinica·2025
Same author

Pharmacogenomics in Oncology-Running Out of Excuses for Slow Adoption.

JAMA network open·2024

Area of Science:

  • Oncology
  • Pharmacogenomics
  • Genetics

Background:

  • Patient response to chemotherapy varies significantly.
  • Pharmacogenomics studies inherited differences in drug metabolism and effects.
  • Cancer therapies often exhibit unpredictable efficacy and severe toxicity.

Purpose of the Study:

  • To review gene polymorphisms influencing cancer therapy outcomes.
  • To explore whole-genome expression studies in cancer pharmacogenomics.
  • To discuss the use of mouse models in pharmacogenomic discovery for cancer.

Main Methods:

  • Review of clinically relevant gene polymorphisms.
  • Analysis of whole-genome expression studies using microarray technology.
  • Evaluation of experimental systems, including mouse models.

Related Experiment Videos

Main Results:

  • Genetic polymorphisms significantly impact chemotherapy efficacy and toxicity.
  • Microarray technology shows promise for advancing cancer pharmacogenomics.
  • Mouse models are valuable tools for pharmacogenomic research in oncology.

Conclusions:

  • Pharmacogenomics is crucial for personalizing cancer treatment.
  • Understanding genetic variations can optimize drug selection and dosage.
  • Further research, including animal models, will enhance precision oncology.